Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgane Cheminant

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Blood|September 27, 2022
Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunityMorgane Cheminant, Thomas A Fox, Mickael Alligon, et al.
The Journal of Infection|October 10, 2022
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiationXavier de Lamballerie, Guillaume Martin-Blondel, Axelle Dupont, et al.
Nature Medicine|May 14, 2024
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trialRoch Houot, Emmanuel Bachy, Guillaume Cartron, et al.
Nature Medicine|September 14, 2023
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trialRoch Houot, Emmanuel Bachy, Guillaume Cartron, et al.
Journal of the American Academy of Dermatology|September 29, 2024
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide studyClaire Guillemin, Nathalia Bellon, Marie Jachiet, et al.
Blood|June 11, 2025
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatmentAlexis Claudel, Anne-Ségolène Cottereau, Emmanuel Bachy, et al.
The Lancet. Rheumatology|March 2, 2025
Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based studyJerome Hadjadj, Anna Wolfers, Oleg Borisov, et al.
Journal of Clinical Immunology|November 5, 2025
Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature reviewLeïla Lefevre, Olivier Paccoud, Bénédicte Neven, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2023
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndromeOlivier Pellé, Solange Moreno, Myriam Ricarda Lorenz, et al.
The Journal of Infection|February 7, 2023
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mgFranck Touret, Guillaume Martin-Blondel, Xavier de Lamballerie, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Blood|September 27, 2022
Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunityMorgane Cheminant, Thomas A Fox, Mickael Alligon, et al.
The Journal of Infection|October 10, 2022
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiationXavier de Lamballerie, Guillaume Martin-Blondel, Axelle Dupont, et al.
Nature Medicine|May 14, 2024
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trialRoch Houot, Emmanuel Bachy, Guillaume Cartron, et al.
Nature Medicine|September 14, 2023
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trialRoch Houot, Emmanuel Bachy, Guillaume Cartron, et al.
Journal of the American Academy of Dermatology|September 29, 2024
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide studyClaire Guillemin, Nathalia Bellon, Marie Jachiet, et al.
Blood|June 11, 2025
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatmentAlexis Claudel, Anne-Ségolène Cottereau, Emmanuel Bachy, et al.
The Lancet. Rheumatology|March 2, 2025
Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based studyJerome Hadjadj, Anna Wolfers, Oleg Borisov, et al.
Journal of Clinical Immunology|November 5, 2025
Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature reviewLeïla Lefevre, Olivier Paccoud, Bénédicte Neven, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2023
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndromeOlivier Pellé, Solange Moreno, Myriam Ricarda Lorenz, et al.
The Journal of Infection|February 7, 2023
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mgFranck Touret, Guillaume Martin-Blondel, Xavier de Lamballerie, et al.
Pageof 8